FDA
-
-
-
-
-
-
-
Baxter Reports Third-Quarter 2025 Results
-
-
-
-
-
-
-
Baxter Reports First-Quarter 2025 Results
-
-
-
-
-
-
-
Baxter Reports Second-Quarter 2024 Results
-
-
-
-
-
-
-
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
-
-
-
-
-
-
-
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
-
-
-
-
-
-
-
Nuwellis, Inc. Announces Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioXcel, Seagate, and Baxter and Encourages Investors to Contact the Firm
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

